Chengye Medical Announces Shareholder Dividend Distribution Resolved by Its Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.

Key facts

  • Chengye Medical Announces Shareholder Dividend Distribution Resolved by Its Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd.
  • Fu Kang Active Pharmaceutical Co., Ltd., a key subsidiary of Chengye Medical, has announced the distribution of cash dividends amounting to NT$77,475,270, as resolved by its shareholders' meeting.
  • Source: PR Times
  • Date: June 26, 2026

Direct answer

Fu Kang Active Pharmaceutical Co., Ltd., a key subsidiary of Chengye Medical, has announced the distribution of cash dividends amounting to NT$77,475,270, as resolved by its shareholders' meeting.

Citation
Chengye Medical Announces Shareholder Dividend Distribution Resolved by Its Key Subsidiary Fu Kang Active Pharmaceutical Co., Ltd. (June 26, 2026), PR Times
Source
PR Times
Date
June 26, 2026
Fu Kang Active Pharmaceutical Co., Ltd., a key subsidiary of Chengye Medical, has announced the distribution of cash dividends amounting to NT$77,475,270, as resolved by its shareholders' meeting.
その他出典：PR Times

📋 Article Processing Timeline

  • 📰 Published: June 26, 2026 at 09:00
  • 🔍 Collected: June 27, 2026 at 17:00 (32h 0m after Published)
  • 🤖 AI Analyzed: June 27, 2026 at 18:01 (1h 0m after Collected)
1. Board of Directors' Resolution Date: 115/06/26

2. Types and Amounts of Dividends Distributed:
Cash dividend of NT$77,475,270.

3. Other Matters to be Disclosed: None.

FAQ

When will the dividend be paid out?

The payout date is not specified, but it is typically made within 1-2 months after the shareholders' meeting.

What is Fu Kang Active Pharmaceutical's main business?

It primarily engages in the development and distribution of pharmaceutical and health products.

Why is this considered material information?

Significant financial distributions impact investor decisions and are therefore classified as material disclosures.

Back to Newsroom (166)